Role of Lithium Augmentation in the Management of Major Depressive Disorder
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Lithium Augmentation in the Management of Major Depressive Disorder
Authors
Keywords
Lithium, Bipolar Disorder, Depressed Patient, Major Depressive Episode, Lithium Treatment
Journal
CNS DRUGS
Volume 28, Issue 4, Pages 331-342
Publisher
Springer Nature
Online
2014-03-04
DOI
10.1007/s40263-014-0152-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder
- (2013) Janusz K. Rybakowski CNS DRUGS
- Potential Mechanisms of Action of Lithium in Bipolar Disorder
- (2013) Gin S. Malhi et al. CNS DRUGS
- Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder
- (2013) Michael Bauer et al. JOURNAL OF AFFECTIVE DISORDERS
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders
- (2013) Michael Bauer et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study
- (2012) Tomas Hajek et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Is the safety of lithium no longer in the balance?
- (2012) Gin S Malhi et al. LANCET
- Lithium toxicity profile: a systematic review and meta-analysis
- (2012) Rebecca F McKnight et al. LANCET
- Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder
- (2012) Hema Tharoor et al. PSYCHIATRIC GENETICS
- Evidence for association of anACCN1gene variant with response to lithium treatment in Sardinian patients with bipolar disorder
- (2011) Alessio Squassina et al. PHARMACOGENOMICS
- Hyperactivity and Enhanced Curiosity of Mice Expressing PKB/SGK-resistant Glycogen Synthase Kinase-3 (GSK-3)
- (2010) Teresa F. Ackermann et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Excellent lithium responders have normal cognitive functions and plasma BDNF levels
- (2010) Janusz K. Rybakowski et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Predictors of efficacy in lithium augmentation for treatment-resistant depression
- (2010) Hiroko Sugawara et al. JOURNAL OF AFFECTIVE DISORDERS
- Lithium’s Emerging Role in the Treatment of Refractory Major Depressive Episodes: Augmentation of Antidepressants
- (2010) Michael Bauer et al. NEUROPSYCHOBIOLOGY
- A Genomewide Association Study of Response to Lithium for Prevention of Recurrence in Bipolar Disorder
- (2009) Roy H. Perlis et al. AMERICAN JOURNAL OF PSYCHIATRY
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
- (2009) J. Craig Nelson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus
- (2009) Michael D. Hammonds et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons
- (2009) Kathrin Scheuch et al. BRAIN RESEARCH
- Lithium: Updated Human Knowledge Using an Evidence-Based Approach
- (2009) Etienne Marc Grandjean et al. CNS DRUGS
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults
- (2009) Sidney H. Kennedy et al. JOURNAL OF AFFECTIVE DISORDERS
- A Longitudinal Study of the Effects of Lithium Treatment on Prefrontal and Subgenual Prefrontal Gray Matter Volume in Treatment-Responsive Bipolar Disorder Patients
- (2009) Gregory J. Moore et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dopamine D1 Receptor Gene Polymorphism is Associated with Prophylactic Lithium Response in Bipolar Disorder
- (2009) J. Rybakowski et al. PHARMACOPSYCHIATRY
- Serotonin transporter gene and response to lithium augmentation in depression
- (2009) Thomas J. Stamm et al. PSYCHIATRIC GENETICS
- Augmentation strategies for treatment-resistant depression
- (2008) André F Carvalho et al. CURRENT OPINION IN PSYCHIATRY
- Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease
- (2008) Camila Teixeira Mendes et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study
- (2008) Michael Bauer et al. EUROPEAN PSYCHIATRY
- Association studies of theBDNFand theNTRK2gene polymorphisms with prophylactic lithium response in bipolar patients
- (2008) Monika Dmitrzak-Weglarz et al. PHARMACOGENOMICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started